This invention refers to the use of an adenovirus for cancer treatment, being this adenovirus defective in its virus-associated (VA) RNAs. Said adenovirus has a mutation in the VAI or VAII gene sequence or both. This adenovirus may also have mutations in the sequences controlling expression of the VA RNAs.

 
Web www.patentalert.com

< Systemic gene delivery vehicles for the treatment of tumors

> Human anti-IFN-.gamma. neutralizing antibodies as selective IFN-.gamma. pathway inhibitors

~ 00420